Cited by 114Amyotrophic Lateral Sclerosis ResearchAutophagy in Disease and TherapyUbiquitin and proteasome pathways

Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP‐43

Urushitani, Makoto, Sato, Takashi, Bamba, Hitoshi, Hisa, Yasuo, Tooyama, Ikuo·2010·Journal of Neuroscience Research

Abstract

Cytoplasmic aggregates of ubiquitinated TAR DNA‐binding protein 43 (TDP‐43) are a pathological hallmark of amyotrophic lateral sclerosis (ALS). However, the mechanism of TDP‐43 polyubiquitination remains elusive. We investigated the effect of nuclear exclusion of TDP‐43 on aggregate formation and fragmentation, using TDP‐43 expression constructs for WT or mutant TDP‐43 with a modified nuclear localizing signal (LQ‐NLS). Overexpression of the LQ‐NLS mutant alone induced no detectable cytoplasmic aggregates during a 72‐hr period. Polyubiquitination of both WT TDP‐43 and the LQ‐NLS mutant was similar in total cell lysates exposed to the proteasome inhibitor lactacystin. However, analysis of subcellular fractions demonstrated a higher concentration of polyubiquitinated TDP‐43 in the nuclear fraction than in the cytosol for WT, and vice versa for the LQ‐NLS mutant. Polyubiquitin‐charged WT and mutant TDP‐43 were highly concentrated in the membrane/microsome fraction, which was also positive for the autophagosome marker LC3. In addition, the autophagy inhibitor 3‐methyladenine (3MA) blocked degradation of both TDP‐43 types, whereas lactacystin was minimally restorative. Furthermore, lactacystin plus 3MA induced prominent cytoplasmic aggregates. We also demonstrated mediation of TDP‐43 polyubiquitination by lysine 48 of ubiquitin, indicating a degradation signal in both TDP‐43 types. This is the first report delineating the distribution of polyubiquitinated TDP‐43 and the degradation pathway of TDP‐43 and clarifying the crucial role of autophagosomes in TDP‐43 clearance. We also demonstrate that nuclear exclusion itself is not an immediate trigger for ALS pathology. Further clarification of the mechanism of polyubiquitination of TDP‐43 and the role of autophagosomes may help in understanding and treating ALS. © 2009 Wiley‐Liss, Inc.

Integrity signals

Registry

Crossref · 10.1002/jnr.22243

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inhibition of MTOR reduces TARDBP aggregation and toxicity in multiple cell and animal models of ALS.

    “Inhibition of MTOR likewise reduces TARDBP aggregation and toxicity in multiple cell and animal models of ALS [353,358,359].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Urushitani, M., Sato, T., Bamba, H., Hisa, Y., & Tooyama, I.
Affiliations
  • Shiga University of Medical Science (JP)
  • Kyoto Prefectural University of Medicine (JP)
Corresponding author
Urushitani, Makoto
Venue
Journal of Neuroscience Research
Publisher
Wiley
Published
2009-10
Volume
88
Issue
4
Pages
784-797
ISSN
  • 0360-4012 (ISSN-L)
  • 1097-4547
OpenAlex
W2104199101
Cited by
114
References
29
Citations by year
2026: 7 · 2025: 4 · 2024: 1 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 3 · 2014: 10 · 2013: 5 · 2012: 9
FWCI
6.17
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroscience Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
TDP-43, polyubiquitination, amyotrophic lateral sclerosis, autophagy, proteasome, nuclear exclusion, cytoplasmic aggregates, protein degradation, LC3, 3-methyladenine, lactacystin
MeSH terms
Acetylcysteine, Adenine, Analysis of Variance, Autophagy, Cell Nucleus, DNA-Binding Proteins, Dose-Response Relationship, Drug, Drug Synergism, Humans, Mutation, Neuroblastoma, Subcellular Fractions, Transfection, Cysteine Proteinase Inhibitors, Protein Transport, Ubiquitin-Protein Ligases, Cell Line, Tumor, Proteasome Endopeptidase Complex, Green Fluorescent Proteins, Ubiquitination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review